QIAGEN Completes U.S. QIAstat-Dx Bloodstream Infection Portfolio With FDA Clearance of New Bacteria Detection Panel

Go back to QIAGEN Completes U.S. QIAstat-Dx Bloodstream Infection Portfolio With FDA Clearance of New Bacteria Detection Panel
Qiagen NV (NYSE: QGEN) Delayed: 50.00 +1.10 (2.25%)
Previous Close $48.90    52 Week High $28.50 
Open $48.12    52 Week Low $19.94 
Day High $50.25    P/E 172.41 
Day Low $46.89    EPS $0.29 
Volume 12,345,387